Subcellular Partitioning and Intra-Macrophage Selectivity of Antimicrobial Compounds Against Mycobacterium tuberculosis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28052847)

Published in Antimicrob Agents Chemother on January 04, 2017

Authors

Michael D Schump1, Douglas M Fox2, Carolyn R Bertozzi3,2,4, Lee W Riley5

Author Affiliations

1: Graduate Group in Infectious Diseases and Immunity, School of Public Health, University of California, Berkeley, California, USA.
2: Department of Chemistry, University of California, Berkeley, California, USA.
3: Department of Bioengineering, University of California, Berkeley, California, USA.
4: Department of Chemistry and Howard Hughes Medical Institute, Stanford University, Stanford, California, USA.
5: Graduate Group in Infectious Diseases and Immunity, School of Public Health, University of California, Berkeley, California, USA lwriley@berkeley.edu.

Articles cited by this

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 26.76

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med (2003) 14.40

Commentary. Lysosomotropic agents. Biochem Pharmacol (1974) 12.28

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet (2010) 10.21

Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science (1994) 10.04

Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J Cell Biol (1981) 6.63

Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis (2010) 5.14

The curious characteristics of pyrazinamide: a review. Int J Tuberc Lung Dis (2003) 4.48

Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2002) 4.10

Non-ionic diffusion and the excretion of weak acids and bases. Am J Med (1958) 4.09

Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation. Proc Natl Acad Sci U S A (2004) 2.86

Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev (2007) 2.42

Uptake of antibiotics by human alveolar macrophages. Am Rev Respir Dis (1984) 2.08

Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug. Br J Pharmacol (2005) 1.88

Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther (2000) 1.87

High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions. Anal Chem (2011) 1.64

Uptake and activity of rifapentine in human peritoneal macrophages and polymorphonuclear leukocytes. Eur J Clin Microbiol (1987) 1.55

Influence of conversion of penicillin G into a basic derivative on its accumulation and subcellular localization in cultured macrophages. Antimicrob Agents Chemother (1987) 1.53

Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth. PLoS Pathog (2014) 1.51

Acid resistance in Mycobacterium tuberculosis. J Bacteriol (2009) 1.48

Case history: the discovery of fluoxetine hydrochloride (Prozac). Nat Rev Drug Discov (2005) 1.32

The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections. Antimicrob Agents Chemother (2012) 1.32

Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages. Antimicrob Agents Chemother (2009) 1.30

Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother (2012) 1.17

Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications. J Pharm Sci (2007) 1.11

Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis. Proc Natl Acad Sci U S A (2015) 1.08

The potential role of lysosomes in tissue distribution of weak bases. Biopharm Drug Dispos (1989) 1.05

R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study. Neuropsychopharmacology (2002) 1.05

Screening for phospholipidosis induced by central nervous drugs: comparing the predictivity of an in vitro assay to high throughput in silico assays. Toxicol In Vitro (2010) 1.02

The Mycobacterium tuberculosis SecA2 system subverts phagosome maturation to promote growth in macrophages. Infect Immun (2012) 1.00

Antimicrobial activity of psychotropic drugs: selective serotonin reuptake inhibitors. Int J Antimicrob Agents (2000) 0.98

Mycobacterium requires an all-around closely apposing phagosome membrane to maintain the maturation block and this apposition is re-established when it rescues itself from phagolysosomes. Cell Microbiol (2009) 0.96

Noninvasive determination of 2-[18F]-fluoroisonicotinic acid hydrazide pharmacokinetics by positron emission tomography in Mycobacterium tuberculosis-infected mice. Antimicrob Agents Chemother (2012) 0.96

Inhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazinamide, and two metabolites of vitamin D3. Antimicrob Agents Chemother (1990) 0.96

Clofazimine crystals in alveolar macrophages from a patient with the acquired immunodeficiency syndrome. Arch Pathol Lab Med (1992) 0.93

Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs. Pharmacol Toxicol (1997) 0.91

Radiosynthesis and bioimaging of the tuberculosis chemotherapeutics isoniazid, rifampicin and pyrazinamide in baboons. J Med Chem (2010) 0.90

Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli. J Antimicrob Chemother (2011) 0.88

Specific uptake of serotonin by murine macrophages. Life Sci (1988) 0.86

Influence of ion gradients on the transbilayer distribution of dibucaine in large unilamellar vesicles. Biochemistry (1988) 0.86

The action of Clofazimine on the level of lysosomal enzymes of cultured macrophages. Clin Exp Immunol (1982) 0.84

Clofazimine. Tuberculosis (Edinb) (2008) 0.82

Clofazimine crystals in the cytoplasm of pulmonary macrophages. Ann Pharmacother (1999) 0.82

Intracellular pharmacokinetics of telithromycin, a ketolide antibiotic, in alveolar macrophages. J Pharm Pharmacol (2010) 0.78

Pulmonary clofazimine crystals in a child with acquired immunodeficiency syndrome and disseminated Mycobacterium avium-intracellulare infection. Pediatr Infect Dis J (1988) 0.78

Negative images due to clofazimine crystals simulating MAI infection in a bronchoalveolar lavage specimen. Diagn Cytopathol (1993) 0.77

[Investigation of antibacterial activity of sertralin]. Mikrobiyol Bul (2009) 0.76